Evolutionary Genomics, Inc. FNAM
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 100.00% | -127.59% | -- | -- | -- |
| Gross Profit | -100.00% | 127.59% | -- | -- | -- |
| SG&A Expenses | -2.84% | -0.73% | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -30.01% | -44.29% | -- | -- | -- |
| Operating Income | 30.01% | 44.29% | -- | -- | -- |
| Income Before Tax | 30.74% | 40.87% | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 30.74% | 40.87% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.74% | 40.87% | -- | -- | -- |
| EBIT | 30.01% | 44.29% | -- | -- | -- |
| EBITDA | 46.01% | 57.86% | -- | -- | -- |
| EPS Basic | 33.21% | 41.07% | -- | -- | -- |
| Normalized Basic EPS | 38.46% | 47.36% | -- | -- | -- |
| EPS Diluted | 33.74% | 41.42% | -- | -- | -- |
| Normalized Diluted EPS | 38.46% | 47.36% | -- | -- | -- |
| Average Basic Shares Outstanding | 9.81% | 6.51% | -- | -- | -- |
| Average Diluted Shares Outstanding | 9.81% | 6.51% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |